Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential.
about
Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Combination of a thioxodihydro ...... d shows preclinical potential.
@en
Combination of a thioxodihydro ...... an cancer stem cell-like cells
@nl
type
label
Combination of a thioxodihydro ...... d shows preclinical potential.
@en
Combination of a thioxodihydro ...... an cancer stem cell-like cells
@nl
prefLabel
Combination of a thioxodihydro ...... d shows preclinical potential.
@en
Combination of a thioxodihydro ...... an cancer stem cell-like cells
@nl
P2093
P2860
P356
P1433
P1476
Combination of a thioxodihydro ...... d shows preclinical potential.
@en
P2093
Bennett Van Houten
Joseph Salamoun
Robert Edwards
P2860
P304
P356
10.18632/ONCOTARGET.23679
P407
P50
P577
2017-12-26T00:00:00Z